National Australia Bank Advised Of Referral To AUSTRAC Enforcement Team; Stock Down

Shares of National Australia Bank Ltd. (NAUBF.PK,NABZY.PK, NAB.AX) or NAB were losing around 3 percent in Australian trading after Australian Transaction Reports and Analysis Centre or AUSTRAC informed that it has identified serious concerns with NAB's compliance with the Anti-Money Laundering or AML and Counter-Terrorism Financing or CTF Act 2006 and the Anti-Money Laundering and Counter-Terrorism Financing Rules 2007.

The concerns have been referred to AUSTRAC's enforcement team, which has initiated a formal enforcement investigation.

In a letter dated June 4, AUSTRAC advised NAB that it is the agency's view that there is "potential serious and ongoing non-compliance" with customer identification procedures, ongoing customer due diligence and compliance with Part A of NAB's AML/CTF Program.

The Australian government financial intelligence agency stated that it has not made any decision about whether or not enforcement action would be taken. According to AUSTRAC, at this stage, it is not considering civil penalty proceedings and that this decision is "reflective of the work undertaken" by NAB to date.

NAB has disclosed the existence of AML/CTF compliance issues in various public disclosures since 2017, including most recently in NAB's 2021 Half Year Financial Report

NAB CEO Ross McEwan said NAB would continue to cooperate with AUSTRAC in its investigations.

Since June 2017, NAB has invested about A$800 million as part of a multi-year program to uplift its financial crime and fraud controls.

In Australia, NAB shares were trading at A$26.69, down 2.98 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT